These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 34007167)

  • 1. Erratum: Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1285. PubMed ID: 34007167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive saliva swallowing test and water swallowing test may identify a COPD phenotype at high risk of exacerbation.
    Yoshimatsu Y; Tobino K; Sueyasu T; Nishizawa S; Goto Y; Murakami K; Munechika M; Yoshimine K; Miyajima H
    Clin Respir J; 2019 May; 13(5):321-327. PubMed ID: 30821113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive Saliva Swallowing Test Predicts COPD Exacerbation.
    Yoshimatsu Y; Tobino K; Sueyasu T; Nishizawa S; Ko Y; Yasuda M; Ide H; Tsuruno K; Miyajima H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2777-2785. PubMed ID: 31824143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2019; 14():mmclxxiii. PubMed ID: 31571854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2451-2452. PubMed ID: 36213087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum].
    J Inflamm Res; 2022; 15():1993-1994. PubMed ID: 35360450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2393-2395. PubMed ID: 34447246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():853. PubMed ID: 33824585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1413. PubMed ID: 34040368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():869. PubMed ID: 32368032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():247-248. PubMed ID: 32099349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Image-Enhanced Bronchoscopic Evaluation of Bronchial Mucosal Microvasculature in COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1-2. PubMed ID: 35023910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():901. PubMed ID: 32425515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Impaired Training-Induced Adaptation of Blood Pressure in COPD Patients: Implication of the Muscle Capillary Bed [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1739. PubMed ID: 32801676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1347-1348. PubMed ID: 34017171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3239-3241. PubMed ID: 34880608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1177. PubMed ID: 32581524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Progression Of Physical Inactivity In COPD Patients: The Effect Of Time And Climate Conditions - A Multicenter Prospective Cohort Study [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2375. PubMed ID: 31695356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2789-2790. PubMed ID: 36330053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2559. PubMed ID: 33116472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.